Table II.
MAPC contribution to hematopoietic stem and progenitor populations in secondary recipients
| Source of primary BM | ||
|---|---|---|
| Population | KTLS | MAPCs |
| LT-HSC | 69.6 ± 12% | 64.6 ± 27% |
| CLP | 56.9 ± 9% | 57.4 ± 18% |
| CMP | 63.5 ± 21% | 37.4 ± 27% |
| GMP | 64.3 ± 22% | 38.9 ± 30% |
| MEP | 62.5 ± 21% | 36.4 ± 27% |
0.75 × 106 eGFP MAPCs were transplanted into lethally irradiated NOD-SCID mice with 2 × 105 Sca-1–depleted cells of host origin. 20 wk after transplant, 106 BM cells were serially transplanted into lethally irradiated C57BL-CD45.1+ hosts. At week 24, BM was harvested and assessed for primary donor (eGFP+CD45.2+) contribution to LT-HSCs (KLSFlk2−CD34−), common lymphoid progenitors (CLP; Lin−ckitlowSca-1lowIL7Rα+Flk2+), common myeloid progenitors (CMP; Lin−ckit+ Sca-1−CD16/32lowCD34+), granulocyte macrophage progenitors (GMP; Lin−ckit+Sca-1−CD16/32+CD34+), and megakaryocyte erythrocyte progenitors (MEP; Lin−ckit+Sca-1−CD16/32lowCD34−). Data for n ≥ 3 mice per group is shown.